Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tendyne Holdings Inc.

Division of Abbott Laboratories Inc.
www.tendyne.com

Latest From Tendyne Holdings Inc.

Abbott Advances Transcath Mitral Valve Efforts With Cephea Acquisition

Abbott has exercised an option to buy Cephea Valve Technologies, developer of a minimally-invasive replacement heart valve, for an undisclosed sum.

Cardiovascular M & A

Edwards Declares Victory In Transcatheter Mitral Valve Contract Suit

A jury recommended a $70m award to Edwards Lifesciences unit CardiAQ based on findings that another firm, Neovasc, breached a supplier contract and used CardiAQ's trade secrets to develop a competing transcatheter mitral valve device.

Medical Device Legal Issues

Medtechs Bet On Transcatheter Mitral Valve Repair

The success of transcatheter aortic valve replacement has generated optimism that the much larger pool of mitral regurgitation patients can be similarly served. While big strategics bet on replacement, however, other companies are betting on repair, developing less invasive devices inspired by an array of established mitral valve surgical repair techniques.

Medical Device

Millipede's Play In Percutaneous Mitral Valve Repair

As medtech strategics race to develop a percutaneously deliverable replacement mitral valve for patients with mitral regurgitation, start-ups tackle an array of mitral repair strategies. Building on a tried-and-true surgical approach, Millipede is developing a catheter-delivered adjustable annuloplasty ring that reduces annular dilation of the mitral valve in order to reduce or eliminate mitral regurgitation.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Abbott Laboratories Inc.
  • Senior Management
  • Jeff Franco, Pres. & CEO
  • Contact Info
  • Tendyne Holdings Inc.
    Phone: (651) 289-5500
    2825 Fairview Ave. North
    Roseville , MN 55113
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register